Product Information
IPRATROPIUM BR 0.02% SOLN is a generic product labeled by Nephron Pharmaceuticals Corporation, priced at $0.1040 per ML under NDC 00487980125. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 27, 2001. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2.5mL
Manufacturer
Nephron Pharmaceuticals CorporationNDC
00487980125
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075562FDA Approved
9/27/2001
TE Code
AN
On Market Since
9/27/2001
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM BR 0.02% SOLN has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 90.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1040 per ML |
|---|---|
| All-time high | $0.1080 (Jul 15, 2026) |
| All-time low | $0.0463 (Oct 19, 2016) |
| 52-week high | $0.1080 |
| 52-week low | $0.0941 |
| Median price | $0.0562 |
| Average price | $0.0644 |
| Largest weekly change | +37.0% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nephron Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM BR 0.02% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM BR 0.02% SOLN, manufactured by Nephron Pharmaceuticals Corporation, is $0.1040 per ML (NDC 00487980125), effective Sep 30, 2026.
How has the price of IPRATROPIUM BR 0.02% SOLN changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM BR 0.02% SOLN has risen 90.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM BR 0.02% SOLN?
Since Nov 28, 2013, the NADAC for IPRATROPIUM BR 0.02% SOLN has ranged from a low of $0.0463 (Oct 19, 2016) to a high of $0.1080 (Jul 15, 2026), with a median of $0.0562 per ML.
Are there cheaper alternatives to IPRATROPIUM BR 0.02% SOLN?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IPRATROPIUM BR 0.02% SOLN, is $0.0529 per ML — about 49% below IPRATROPIUM BR 0.02% SOLN.
Who manufactures IPRATROPIUM BR 0.02% SOLN?
IPRATROPIUM BR 0.02% SOLN (NDC 00487980125) is labeled by Nephron Pharmaceuticals Corporation, and CMS classifies it as a generic product.